MaxCyte, Inc. (MXCT) Misses Q3 EPS by 1c

MaxCyte, Inc. (NASDAQ: MXCT) reported Q3 EPS of ($0.11), $0.01 worse than the analyst estimate of ($0.10). Revenue for the quarter came in at $8 million versus the consensus estimate of $8.87 million.

For earnings history and earnings-related data on MaxCyte, Inc. (MXCT) click here.

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• Silexion Therapeutics (SLXN) Tops Q2 EPS by 793c
• Algorhythm Holdings (RIME) Tops Q2 EPS by 54c